Premium
Which patients with gynaecomastia require more detailed investigation?
Author(s) -
Ali S.N.,
Jayasena C.N.,
Sam A.H.
Publication year - 2018
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.13526
Subject(s) - gynecomastia , medicine , malignancy , endocrinology , disease , testosterone (patch) , kidney , physiology , pathology
Summary Gynaecomastia may be due to medication, chronic liver or kidney disease, hypogonadism (primary or secondary to pituitary disease) or hyperthyroidism. Having excluded these aetiologies, it is imperative to be vigilant for underlying malignancy causing gynaecomastia. These include human chorionic gonadotrophin‐secreting testicular and extratesticular tumours and oestrogen‐secreting testicular tumours and feminising adrenal tumours.